TCR2 Therapeutics Current Ratio 2017-2019 | TCRR

TCR2 Therapeutics current ratio from 2017 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
TCR2 Therapeutics Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-06-30 $0.18B $0.01B 24.54
2019-03-31 $0.17B $0.01B 30.91
2018-12-31 $0.13B $0.01B 22.96
2018-06-30 $0.00B 0.00
2018-03-31 $0.00B 0.00
2017-12-31 $0.02B $0.00B 16.82
2016-12-31 $0.02B $0.00B 17.92
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.363B $0.000B
TCR2 Therapeutics Inc. is a clinical-stage immunotherapy company developing T cell therapies for patients suffering from cancer. Its product candidate includes TC-210, TC-220, TC-410, TC-110 and TC-310 which are in clinical stage. TCR2 Therapeutics Inc. is based in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $61.466B 37.86
Takeda Pharmaceutical (TAK) Japan $54.955B 8.60
Astellas Pharma (ALPMY) Japan $30.027B 14.31
Merck (MKGAF) Germany $14.908B 20.34
Eisai (ESALY) Japan $14.633B 22.40
UCB SA (UCBJF) Belgium $14.373B 0.00
Grifols, S.A (GRFS) Spain $14.157B 18.06
Ono Pharmaceutical (OPHLF) Japan $9.212B 19.69
Ionis Pharmaceuticals (IONS) United States $8.635B 18.62
Neurocrine Biosciences (NBIX) United States $8.562B 0.00
IPSEN SA ADR (IPSEY) France $8.332B 0.00
Sage Therapeutics (SAGE) United States $7.452B 0.00
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.257B 0.00
Catalent (CTLT) United States $7.196B 28.44
Jazz Pharmaceuticals (JAZZ) Ireland $6.684B 8.80
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.118B 0.00
STADA ARZNEIMI (STDAF) Germany $5.547B 0.00
Orion OYJ (ORINY) Finland $5.275B 27.16
Hypermarcas (HYPMY) Brazil $5.194B 18.67
United Therapeutics (UTHR) United States $3.594B 0.00
FibroGen (FGEN) United States $3.378B 84.48
Evotec AG (EVTCY) Germany $3.277B 44.87
Arrowhead Pharmaceuticals (ARWR) United States $3.256B 74.66
Nektar Therapeutics (NKTR) United States $3.031B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.912B 10.44
PTC Therapeutics (PTCT) United States $2.228B 0.00
Tilray (TLRY) Canada $2.160B 0.00
Xencor (XNCR) United States $1.988B 43.35
Zogenix (ZGNX) United States $1.879B 0.00
Portola Pharmaceuticals (PTLA) United States $1.874B 0.00
Corcept Therapeutics (CORT) United States $1.633B 22.44
Pacira Pharmaceuticals (PCRX) United States $1.586B 57.73
USANA Health Sciences (USNA) United States $1.535B 15.39
Heron Therapeutics (HRTX) United States $1.424B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.413B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.308B 0.00
Radius Health (RDUS) United States $1.203B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.171B 19.31
ArQule (ARQL) United States $1.038B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.956B 0.00
TherapeuticsMD (TXMD) United States $0.944B 0.00
Aerie Pharmaceuticals (AERI) United States $0.932B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.873B 3.89
Spectrum Pharmaceuticals (SPPI) United States $0.870B 0.00
Dova Pharmaceuticals (DOVA) United States $0.809B 0.00
Endo (ENDP) Ireland $0.790B 1.39
Organogenesis Holdings (ORGO) United States $0.719B 0.00
Karyopharm Therapeutics (KPTI) United States $0.647B 0.00
Concordia (CXRXF) Canada $0.588B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.542B 0.00
Flexion Therapeutics (FLXN) United States $0.539B 0.00
Akebia Therapeutics (AKBA) United States $0.513B 0.00
Indivior (INVVY) United States $0.473B 1.71
Aptorum Group (APM) Hong Kong, SAR China $0.466B 0.00
Lannett Co Inc (LCI) United States $0.453B 4.77
ChemoCentryx (CCXI) United States $0.450B 0.00
Siga Technologies (SIGA) United States $0.446B 1.04
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.440B 0.00
Translate Bio (TBIO) United States $0.426B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.406B 0.00
Collegium Pharmaceutical (COLL) United States $0.403B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.366B 16.64
ImmunoGen (IMGN) United States $0.366B 0.00
Innate Pharma SA (IPHYF) France $0.363B 0.00
DURECT (DRRX) United States $0.355B 0.00
Rafael Holdings (RFL) United States $0.334B 0.00
Harpoon Therapeutics (HARP) United States $0.324B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.313B 0.00
OptiNose (OPTN) United States $0.293B 0.00
Dermira (DERM) United States $0.289B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.283B 0.00
Ardelyx (ARDX) United States $0.277B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.276B 0.00
Molecular Templates (MTEM) United States $0.260B 0.00
Recro Pharma (REPH) United States $0.258B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.227B 0.00
Xeris Pharmaceuticals (XERS) United States $0.217B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.206B 0.00
GlycoMimetics (GLYC) United States $0.199B 0.00
CannTrust Holdings (CTST) Canada $0.195B 0.00
CV Sciences (CVSI) United States $0.193B 0.00
KalVista Pharmaceuticals (KALV) United States $0.191B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.183B 0.00
Nature's Sunshine Products (NATR) United States $0.182B 30.45
AcelRx Pharmaceuticals (ACRX) United States $0.175B 0.00
Taiwan Liposome (TLC) Taiwan $0.168B 0.00
Ocular Therapeutix (OCUL) United States $0.156B 0.00
Concert Pharmaceuticals (CNCE) United States $0.148B 0.00
Calithera Biosciences (CALA) United States $0.140B 0.00
Redhill Biopharma (RDHL) Israel $0.136B 0.00
IMV INC (IMV) Canada $0.129B 0.00
Generex Biotechnology (GNBT) United States $0.129B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.128B 0.00
MEI Pharma (MEIP) United States $0.119B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.117B 0.00
Jounce Therapeutics (JNCE) United States $0.110B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.109B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Cardiome Pharma (CORV) Canada $0.090B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.085B 32.53
Aquestive Therapeutics (AQST) United States $0.084B 0.00
Majesco Entertainment (PTE) United States $0.081B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.081B 0.00
MediWound (MDWD) Israel $0.081B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.076B 0.00
Lipocine (LPCN) United States $0.072B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.071B 0.00
Genocea Biosciences (GNCA) United States $0.070B 0.00
Neos Therapeutics (NEOS) United States $0.070B 0.00
Otonomy (OTIC) United States $0.068B 0.00
Champions Oncology (CSBR) United States $0.067B 0.00
Infinity Pharmaceuticals (INFI) United States $0.066B 0.00
AgeX Therapeutics (AGE) United States $0.065B 0.00
Natural Alternatives (NAII) United States $0.065B 9.73
Novan (NOVN) United States $0.062B 0.00
IntelGenx Technologies (IGXT) Canada $0.062B 0.00
SCYNEXIS (SCYX) United States $0.061B 0.00
Aclaris Therapeutics (ACRS) United States $0.061B 0.00
Melinta Therapeutics (MLNT) United States $0.057B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.057B 0.00
ElectroCore (ECOR) United States $0.056B 0.00
Pharmaxis (PXSLY) Australia $0.055B 0.00
Iterum Therapeutics (ITRM) Ireland $0.055B 0.00
Nivalis Therapeutics (ALPN) United States $0.054B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.051B 0.00
Capnia (SLNO) United States $0.050B 0.00
Forward Pharma (FWP) Denmark $0.046B 0.00
CTI BioPharma (CTIC) United States $0.044B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.043B 0.00
Mannatechorporated (MTEX) United States $0.040B 0.00
Mast Therapeutics (SVRA) United States $0.038B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.037B 0.00
India Globalization Capital (IGC) United States $0.036B 0.00
Jaguar Animal Health (JAGX) United States $0.033B 0.00
Bio-Path Holdings (BPTH) United States $0.032B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.031B 0.00
PharmAthene (ALT) United States $0.031B 0.00
Opexa Therapeutics (ACER) United States $0.031B 0.00
China SXT Pharmaceuticals (SXTC) China $0.031B 0.00
Biomerica (BMRA) United States $0.030B 0.00
ProPhase Labs (PRPH) United States $0.022B 0.00
IsoRay (ISR) United States $0.021B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.016B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Cyanotech (CYAN) United States $0.014B 0.00
Regulus Therapeutics (RGLS) United States $0.014B 0.00
Vical (BBI) United States $0.014B 0.00
Heat Biologics (HTBX) United States $0.013B 0.00
Achieve Life Sciences (ACHV) United States $0.012B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.012B 0.00
Shineco (TYHT) China $0.012B 17.00
HANCOCK JAFFE (HJLI) United States $0.011B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.011B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.007B 0.00
VAXART, INC (VXRT) United States $0.006B 0.00
Onconova Therapeutics (ONTX) United States $0.005B 0.00
RXi Pharmaceuticals (PHIO) United States $0.005B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
Flex Pharma (SLRX) United States $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Can-Fite Biopharma (CANF) Israel $0.003B 0.00
Hemispherx BioPharma (AIM) United States $0.002B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.001B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00